Ci ALLOZYNE INC

Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week. Source: Wikipedia
LiggéeyBiotechnology
Kër bu magSeattle, WA
Sos nañu ko2005
Melokaan yoonC Corporation
NekkinDox

Xool

Amul xool. Liggéey nga ak ALLOZYNE INC? Doon ki njëkk a séddoo sa xam-xam.

Bind xool →

Nimero yu am solo

Duggal ngir gis lim yu am solo yi

Njëg, ñoor bu set ak limu liggéeykat yu ALLOZYNE INC ci at yi, ak fi ñu jële.

Dugg Sos ab kont ak sa imeel

Amul fay

Jokkoo & lëkkalekaay

Barab

Seattle, WA

Ndax sa sosiete la?

Jël xët bii bu amul fay ngir yokk sa logo, yëf, nataal ak liggéey, te tontu xool.

Jël xët bii

Séddoo kompaañi bii

ALLOZYNE INCBiotechnologyhttps://heelky.com/explore/companies/allozyne-inc-64owvf45/

Duppi lëkkalekaay

Séddoo ci

Kood QR

Skane ko ak kameraa telefon ngir ubbi xët wii, walla yebbi ko ngir ab flyer, ab slide walla ab badge.

Bokku ci Heelky ngir jokkoo, jëfandikoo ak yokkte

Sos kont bu amul fay ngir yónnee nit, jot liggéey te yónnee misiyooŋ.

Bokku léegi — amul fay

Tànn sa làkk

Heelky dina fàttali sa tànn.

Yeneen làkk

Làkk yi am: 70 Ci mbiri làkk yi ci Heelky